← FDA Drug Approvals (Drugs@FDA)
MYRBETRIQ
NDA · New Drug Application · Sponsor: APGDI · Approved 2012-06-28
Drug application
- FDA Application #
NDA202611- Application type
- New Drug Application
- Brand name
- MYRBETRIQ
- Generic name
- MIRABEGRON
- Active ingredients
- MIRABEGRON
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- APGDI
- Manufacturer
- Astellas Pharma US, Inc.
- First approval
- 2012-06-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown